Macamides are a distinct class of secondary metabolites, benzylamides of long chain fatty acids, which were isolated from the Peruvian plant Lepidium meyenii (Maca). As structural analogues of the endocannabinoid anandamide (AEA), they have demonstrated neuroprotective effects in vitro and in vivo. The purpose of this study was to demonstrate the neuroprotective activity of the macamides: N-(3-methoxybenzyl)oleamide (MAC 18:1), N-(3-methoxybenzyl)linoleamide (MAC 18:2) and N-(3-methoxybenzyl)linolenamide (MAC 18:3) in a neurotoxic environment caused by exposure of U-87 MG glioblastoma cells to manganese chloride (MnCl 2 ). The neuroprotective effects of these macamides were reversed by the CB 1 antagonist AM251. The mechanism by which manganese (Mn) induces cell damage was investigated by studying its effects on mitochondria. Reactive oxygen species (ROS) increase intracellular calcium and enhance the opening of mitochondrial permeability transition pores (MPTP), which leads to decreased mitochondrial membrane potential (MMP), to disruption of mitochondria and to neuron death in neurodegenerative disorders. In this study, MnCl 2 at 50 μM was responsible for mitochondrial disruption, which was attenuated by all three of the macamides tested. Human peroxisome proliferator-activated receptor gamma (PPARγ) has been proposed to be a cannabinoid target, and PPARγ has also been demonstrated to mediate some of the longer-term vascular effects of the plant cannabinoid, Δ9-tetrahydrocannabinol. PPARγ activation was observed in response to exposures of cells to MAC 18:2 and MAC 18:3. These findings suggest that macamides achieve their neuroprotective effects by binding to CB 1 receptors to protect against Mn-induced toxicity in U-87 MG glioblastoma cells. Additionally these macamides, in a manner similar to the analogous endocannabinoid AEA, interact with other targets such as PPARγ to regulate metabolism and energy homeostasis, cell differentiation and inflammation.
Introduction
Lepidium meyenii (Maca) is a Peruvian plant in the family Brassicaceae (Toledo et al., 1998) . It has been used as a folk medicine for centuries and it is currently used to treat a host of pathological conditions including menopausal symptoms (Lee et al., 2011) , sexual and menstrual disorders Shin et al., 2010) , memory loss (Liu et al., 2011; Rubio et al., 2007) , cancer (Gonzales et al., 2005) and depression . Since it has these reported health benefits, Maca is used as a food supplement (Gonzales, 2007) . Maca contains alkaloids (macaridine, lepidine), isothiocyanates (benzylisothiocyanate, 4-methoxybenzylisothiocyanate), polyunsaturated fatty acids (macaenes), sterols (beta-sitosterol, campesterol, stigmasterol), glucosinolates (glucotropaeolin, glucoalyssin, glucobrassicin), amino acids (leucine, arginine, phenylalanine) and minerals such as potassium, calcium and iron (Gonzales, 2012; PinoFigueroa et al., 2010; Muhammad et al., 2002) . Among the various chemical constituents isolated from the plant are unique, non-polar compounds called macamides (alkamides) which are N-benzylamides of long-chain fatty acids (Esparza et al., 2015; McCollom et al., 2005; Wu et al., 2013; Zhao et al., 2005) . Macamides have been claimed to be responsible for the pharmacological activities of Maca. A structural similarity exists between the endogenous endocannabinoid agonist anandamide (AEA) and the macamides (Fig. 1) , as both are amide derivatives of long-chain fatty acids (Hajdu et al., 2014) .
Recent studies have demonstrated that the pentane extract of Maca and individual macamides act as fatty acid amide hydrolase (FAAH) inhibitors (Almukadi et al., 2013; Hajdu et al., 2014; Pino-Figueroa and Maher, 2009; Wu et al., 2013) . FAAH inhibitors block the hydrolysis of AEA to increase endogenous levels and sustain its duration of action.
This approach of pharmacological modification of an endogenous agonist level would have an advantage over the use of a conventional cell surface receptor agonist, which could have more undesirable side effects. Since FAAH inhibition can only potentiate an activated signaling pathway, the increase of endogenous levels of released lipid signaling molecules at their sites of action provides a temporal and spatial pharmacological control not available with a classical receptor agonist (Otrubova and Boger, 2012) . The results of some studies have indicated that FAAH inhibitors might be useful to treat depression, anxiety, inflammation and pain, as well as neurodegenerative diseases such as Parkinson's disease (PD, Boger et al., 2000; Piomelli et al., 2006) . MAC 18:1, MAC 18:2 and MAC 18:3 are the natural derivatives of N-benzyloleamide, N-benzyllinoleamide and N-benzyllinolenamide, respectively. The methoxy group in the MAC structures, which is an electron-donating group, might donate electrons to reactive oxygen species (ROS) or to free radicals generated either by oxidative stress or by pathological insult or injury, thereby neutralizing toxic effects and promoting cell proliferation. The methoxy group might also interact with intracellular targets to afford its neuroprotective effects.
Manganese (Mn) is an essential trace element, which is necessary in physiological processes that support development, growth, and neuron function. However, increased exposure or decreased excretion will eventually lead to Mn accumulation in basal ganglia in the brain and can trigger Parkinson-like effects, referred to as manganism (Kwakye et al., 2015) . Manganese toxicity is characterized by motor and sensory disturbances, as well as by psychiatric and cognitive deficits (Peres et al., 2016) . Manganism is distinct from idiopathic PD, in which dopaminergic soma of the substantia nigra pars compacta is selectively impaired (Perl and Olanow, 2007) . Interestingly, appearance of Lewy bodies (another characteristic feature of PD) are unobserved in manganism. Moreover, therapeutic response to levodopa, a drug used to treat early stages of PD, is ineffective against Mn-induced parkinsonism (Kwakye et al., 2015) .
Oxidative stress is one of the putative mechanisms by which Mn can induce cell death (Chtourou et al., 2011) . Mn accumulates in mitochondria via facilitated diffusion and receptor-gated cation channels (Chtourou et al., 2011) . This accumulation interferes with the electron transport chain (ETC), leading to enhanced production of ROS such as superoxide radicals (Gavin et al., 1999) . Mn also induces dose-dependent inhibition of respiratory complexes and ROS generation in mitochondria isolated from rat brain (Zhang et al., 2003) ; this ROS generation might be decreased by treatment with antioxidants (Pandya et al., 2013) . It is well documented in the literature that Mn is capable to depolarize mitochondria to an extent to cause severe adverse effects on adenosine triphosphate (ATP) production, ETC disruption, and other negative consequences. Therefore, it can be predicted that the Parkinson-like effects due to Mn exposure might be linked to altered mitochondrial functions. These findings make manganese chloride (MnCl 2 ), as a source of Mn, an ideal neurotoxic agent for this study.
We hypothesized that MAC 18:1, MAC 18:2 and MAC 18:3 could counteract Mn-induced neurotoxicity in U-87 MG glioblastoma cells. We investigated the effect of Mn on mitochondrial depolarization, and thereby on the activation of the intrinsic apoptotic pathway. Our results demonstrated that macamides could alleviate the adverse effects of Mn on U-87 MG glioblastoma cells.
Materials and methods

Materials
The compounds of interest: MAC 18:1, MAC 18:2 and MAC 18:3 were synthesized in our laboratory (MCPHS University, Boston) and are identical to macamides isolated from hypocotyls of Lepidium meyenii obtained in Arequipa, Peru . AM251, AM30, A784168 and anisomycin were purchased from Tocris Bioscience (Minneapolis, MN). The tetrazolium compound: 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H utilized in the MTS assay, and the luminescence-based glutathione (GSH) assay were obtained from Promega (Madison, WI). MnCl 2 and dimethyl sulfoxide (DMSO) were supplied by Sigma Aldrich (St. Louis, MO). The Mitoprobe JC-1 assay to measure mitochondrial membrane potential was supplied by Life Technologies (Grand Island, NY). The p38 MAPK alpha (Thr180/Tyr182) In-Cell ELISA kit, utilized to measure p38 MAPK activation was from Abcam (Cambridge, MA). The PPARγ gene reporter assay was from Indigo Biosciences (State College, PA).
Cell culture
Human primary glioblastoma U-87 MG cells (ATCC© HTB-14), Eagle's Minimum Essential Medium (EMEM), fetal bovine serum (FBS), K.S. Gugnani et al. Toxicology and Applied Pharmacology 340 (2018) 67-76 penicillin and streptomycin were obtained from the American Type Culture Collection (ATCC, Manassas, VA). Cells were cultured in EMEM, supplemented with 10% FBS and 1% penicillin/streptomycin. Cells were then grown in a humidified environment with 5% CO 2 until they were confluent.
Cell viability assay
Cells were grown and maintained in 75 cm 2 cell culture flasks at 37°C in a humidified incubator with 5% CO 2 . The MTS reagent was utilized to assess cell viability. Briefly, 1.0 × 10 4 cells/well were seeded in 96-well plates and after a 24 h stabilization period, they were treated with macamides at 0.1-50 μM. DMSO was kept at a concentration no more than 0.5%. After an 1 h incubation with macamides, cells were exposed to a neurotoxic concentration of 10 μM MnCl 2 for 23 h. Following this exposure, MTS was added to each well, and plates were incubated for 3 h. The absorbance was then measured at 490 nm, utilizing a microplate reader (Synergy HT Multi-Mode Microplate Reader, Biotek, Winooski, VT). Percent survival was calculated relative to control wells with vehicle only, which were considered to represent 100% survival.
To determine which receptors were responsible for the neuroprotective activity, receptors presumed to be involved were blocked by antagonists. Cells were exposed to 0.3 μM AM251 (CB 1 antagonist), 0.3 μM AM630 (CB 2 antagonist) or 0.3 μM A 784168 (TRPV 1 antagonist) 3 h before treatment with tested macamides (0.3-10 μM), followed by incubation for 1 h. DMSO was kept at a concentration no more than 0.5%. Subsequently, cells were exposed to a neurotoxic concentration of 10 μM MnCl 2 for 23 h, after which cell viability was determined. Three replicates were performed for each assay.
Measurement of glutathione levels
A luminescence-based assay (Promega) was performed to detect GSH levels. The principle of this assay is that the precursor luciferin-NT is converted to luciferin in the presence of GSH, and this reaction is catalyzed by glutathione S-transferase (GST). A reaction buffer containing luciferase, which produces light as a by-product of luciferin metabolism, was subsequently added and the light intensity (which correlates with GSH levels) was measured with a luminometer. Twentyfour hours after cell seeding, the cells were treated with vehicle or different concentrations of MAC 18:3 (0.1 μM -50 μM) for 1 h. After a 1 h incubation, the cells were incubated with to 10 μM MnCl 2 for 23 h. Relative luminescence units (RLU) were then quantified to GSH as equivalents of μM. Three replicates were performed for each assay.
Measurement of mitochondrial membrane potential (MMP)
The mitochondrial membrane potential of intact cells was monitored with flow cytometry utilizing a fluorescence-activated cell sorting (FACS) method, a fluorescence microplate reader and the lipophilic JC-1 probe. At the end of macamide pre-treatment and MnCl 2 incubation, cells were loaded with JC-1 (2 μM in EMEM) for 15 min at 37°C. After the loading period, the cell suspensions were analyzed for JC-1 fluorescence with a Guava easyCyte Flow Cytometer (EMD Millipore, Burlington, MA). Cells were gated by forward and side scatter, in which a minimum of 5000 cells were analyzed.
U-87 MG cells were seeded at a density of 1.5 × 10 4 cells/well in poly-L-lysine pre-coated 96-well black bottom plates. After exposure to macamides and MnCl 2 , cells were analyzed for JC-1 fluorescence using the Synergy fluorescence microplate reader, with excitation wavelengths between 485 and 530 nm and emission wavelengths between 528 nm and 590 nm. Three replicates were performed for each assay.
PPARγ transactivation
Chinese hamster ovary (CHO) cells overexpressing PPARγ, supplied by Indigo Biosciences, were transfected with a plasmid containing PPRE, incorporated to encode luciferase cDNA. Following subsequent treatments and incubation, these cells were lysed and the luciferase substrate (D-luciferin) was added to each well. The light emitted by the luciferase-luciferin reaction was then monitored with a Synergy microplate reader. The light emitted by this reaction is directly proportional to PPARγ activation. Rosiglitazone (RGZ), a potent PPARγ agonist, was used as a positive control. Four replicates were performed for each assay.
Measurement of p38 mitogen-activated protein kinase (MAPK) activation
U-87 MG cells were seeded into 96-well plates, which were then incubated for 24 h. After treatments with test macamides and with the neurotoxic agent MnCl 2 , the cells were fixed with 8% paraformaldehyde solution. To reduce the activity of endogenous peroxidase, the cells were exposed to 1% hydrogen peroxide. After this blocking, antiphospho-38 MAPK (Thr180/Tyr182) or anti-p38 MAPK (primary antibody) was added to the wells, followed by a 2 h incubation. The wells were washed, and horseradish peroxidase (HRP)-conjugated anti-mouse immunoglobulin G (IgG; secondary antibody) was added to the wells, followed by 1 h incubation. The wells were washed again and a tetramethylbenzidine (TMB) substrate solution was added. In the presence of HRP, TMB produces a blue color which can be measured at 650 nm. The reaction was stopped by adding 0.16 M sulfuric acid and the change in color from blue to yellow was observed. This color change is associated with the generation of oxidized TMB, which can be measured at 450 nm. Anisomycin (30 μM) was used as a positive control. The ratio of anti-phospho-38 MAPK/anti-p38 MAPK represents the extent of p38 MAPK phosphorylation. Three replicates were performed for each assay.
Statistical analysis
Data are reported as mean ± SEM. Comparisons between multiple groups were performed with one-way analysis of variance (ANOVA), or two-way ANOVA for antagonist-based experiments, using GraphPad Prism (GraphPad Software, La Jolla, CA). Results with a p-value ≤ 0.05 (≤ 0.001 for some experiments) were considered statistically significant. Each experiment was performed in three independent replications. GraphPad Prism version 7.04 for Windows (GraphPad Software, La Jolla, CA) was used for the graphic representation of the data. If the p value in the ANOVA test was significant, a post hoc Tukey's test was performed. Graphic abstracts and molecular structures were drawn using ChemDraw Professional (PerkinElmer Infomatics, Waltham, MA).
Results
Macamides counteract Mn-induced toxicity in U-87 MG glioblastoma cells
Exposure of U-87 MG to the three macamides tested, before cells were exposed to 10 μM MnCl 2 , demonstrated that the macamides attenuated Mn-induced toxicity. While exposure to 10 μM MnCl 2 reduced cell viability to 47% of control, cell viability was significantly increased when cells were exposed to the macamides MAC 18:1, MAC 18:2 and MAC 18:3 prior to MnCl 2 exposure; to an average of 65%, 67% and 75% (p ≤ 0.05) of control, respectively, as shown in Figs. 2A , B and C.
Macamides counteract Mn-induced toxicity in U-87 MG glioblastoma cells through a CB 1 -dependent mechanism
The neuroprotective effects of the tested macamides against Mninduced toxicity were severely reduced in response to an exposure to 0.3 μM AM251 (CB 1 antagonist). Exposures of cells to MAC 18:1, MAC 18:2 and MAC 18:3 at concentrations of 0.3, 1, 3 and 10 μM in the presence of 0.3 μM AM251 reduced neuroprotection to 0-20% (p ≤ 0.05) of that observed following exposures to macamides alone (Figs. 3A, B and C) . This result suggests that the macamides' important role to counteract Mn-induced damage, is likely via a CB 1 receptormediated mechanism. The neuroprotective effects of the macamides were unchanged in the presence of AM630 (CB 2 antagonist) and A 784168 (TRPV 1 antagonist), indicating that these receptors are not likely to be involved in the neuroprotective effects of the macamides to protect cells from Mn-induced toxicity.
Macamides increase endogenous levels of antioxidant GSH in the presence of MnCl 2
To further investigate the response of antioxidant defense mechanisms to MnCl 2 exposure, endogenous levels of GSH were measured. Of interest, MnCl 2 exposure alone did not significantly alter the endogenous GSH level (12.8 μM vs 11.6 μM in control). In this study, increases in GSH to 16.3 and 17.5 μM (from 12.8 μM GSH in response to 10 μM MnCl 2 alone, p ≤ 0.05) were observed when high concentrations of MAC 18:3 (10 and 30 μM, respectively) were co-treated with MnCl 2 (Fig. 4) , suggesting that an increase in the antioxidant GSH reduced the toxic effects of Mn. In contrast, MAC 18:1 and MAC 18:2 had no effects on endogenous GSH levels (data not shown).
Macamides counteract Mn-induced mitochondrial depolarization
Neuroprotective effects of macamides on glial U-87 MG cells against Mn-induced toxicity were further studied by examining mitochondrial depolarization utilizing the JC-1 staining technique. This semi-quantitative assay was performed to determine the effects of Mn on the disruption of mitochondria and to discern the ability of the macamides to prevent this disruption. Cells with depolarized mitochondria emit green fluorescence while cells with intact and healthy mitochondria emit red fluorescence. Carbonyl cyanide m-chlorophenyl hydrazine (CCCP) was used as a positive control for its role in reducing MMP by inhibiting key mitochondrial pathways such as oxidative phosphorylation. Low concentrations of MnCl 2 (10 μM) did not result in mitochondrial depolarization as the red/green fluorescence ratio was found to be 14.2, as compared to 17.7 for the control. However, a higher concentration of MnCl 2 (50 μM) resulted in a red/green fluorescence ratio of 4.8, consistent with depolarized mitochondria (Fig. 5A) . The test macamides: MAC 18:1 (0.3, 1 and 3 μM), MAC 18:2 (1, 10 and 30 μM) and MAC 18:3 (1, 3 and 10 μM, p ≤ 0.05) significantly counteracted the mitochondrial depolarization caused by 50 μM MnCl 2 as shown in Figs. 5B, C and D, respectively.
Using FACS, a typical loss of MMP was detected for cells exposed to 50 μM MnCl 2 . As expected, CCCP caused a severe reduction in MMP as 93.9% of cells had depolarized mitochondria (low red fluorescence), thereby confirming the validity of the assay. On the contrary, the 72.7% of cells with depolarized mitochondria in response to 50 μM MnCl 2 alone were significantly reduced by MAC 18:3 pre-treatment to 35.7% (p ≤ 0.05) following exposure to 50 μM MnCl 2 (Fig. 6A) . The high concentration of MnCl 2 (50 μM) resulted in a red/green fluorescence ratio of 1.1, which was increased to 4.2 (p ≤ 0.05) in response to MAC 18:3 and subsequent exposure to 50 μM MnCl 2 (Fig. 6B) . Altogether, these findings suggest that macamides work to counteract Mn-induced mitochondrial depolarization.
Macamides are potential ligands for nuclear receptor PPAR γ
The gene reporter assay was performed to test the ability of macamides to activate PPAR γ receptors. No PPAR γ activation was observed in response to MAC 18:1 exposure (Fig. 7A) . However, MAC 18:2 and Fig. 2 . Evaluation of cell viability of U-87 MG cells exposed to various concentrations of macamides (0.1-50 μM) before a 23 h exposure to 10 μM MnCl 2 . Cell viability was assessed with the MTS assay, and results are presented as percent of control viability. Cells were treated with the indicated concentrations of (A) MAC 18:1, (B) MAC 18:2 and (C) MAC 18:3 to demonstrate neuroprotective effect against Mn-induced toxicity. Data are presented as mean ± SEM (n = 3). In the one-way ANOVA, followed by Tukey's test and compared to the control group (**) and 10 μM MnCl 2 group (*), p ≤ 0.05 was considered significant.
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MAC 18:3 at 30 μM activated PPARγ with EC 50 values of 22.6 ± 0.1 μM (Fig. 7B ) and 20.4 ± 0.1 μM (Fig. 7C) , respectively (p ≤ 0.05). Human PPAR γ activation was observed in the presence of RGZ, with an EC 50 value of 240.8 ± 1.4 nM (Fig. 7D ).
Macamide MAC 18:3 does not counteract Mn-induced p38 MAPK inactivation
Cell-based ELISA was performed to measure p38 MAPK activation in the presence of MAC 18:3. Inactivation of p38 MAPK was observed in the presence of 10 μM MnCl 2 . However, activation of p38 MAPK was not observed in response to treatments with different concentrations of MAC 18:3 in the presence of 10 μM MnCl 2 , as compared to 10 μM MnCl 2 alone. (Fig. 8) .
Discussion
A pentane extract of Maca has been tested in vitro in crayfish neurons (Pino-Figueroa et al., 2010) , and in vivo in rats subjected to focal ischemic stroke (Pino-Figueroa et al., 2011) , and it has been found to have neuroprotective effects. However, the mechanism of action is unknown. The pentane extract, as a whole, possesses a variety of compounds and metabolites such as macamides, alkaloids and macenes (Gonzales, 2012) . Therefore, it is important to study which compounds contribute to the neuroprotective activity in the presence of toxic stimuli.
First, 10 μM MnCl 2 was selected to be the neurotoxic agent to induce toxicity in U-87 MG glioblastoma cells, as it reduced viable cell populations by approximately 50%. The compounds of interest were screened at different concentrations before cells were exposured to 10 μM MnCl 2 , to evaluate their neuroprotective potential. The three compounds at all test concentrations (0.1-50 μM) significantly increased cell viability, counteracting the cell death caused by the neurotoxin, MnCl 2 , when it was administered alone.
Since it is important to study the receptors involved in this neuroprotective effect, we demonstrated that a nontoxic concentration of the CB 1 receptor antagonist AM251 blocked the neuroprotective effects of the macamides tested, while CB 2 and TRPV 1 receptor antagonists were without effect. These results suggest that the neuroprotective effects of the macamides on U-87 MG glioblastoma cells were mediated by CB 1 receptors and not by CB 2 or TRPV 1 receptors. This observation is in agreement with the literature, suggesting the role of this cannabinoid receptor in neuroprotection (Landucci et al., 2011; More and Choi, 2015; Panikashvili et al., 2005; Zogopoulos et al., 2013) . In particular, an in vivo study demonstrated the neuroprotective activity of AEA by a CB 1 -mediated mechanism (Veldhuis et al., 2003; Xu et al., 2017) .
The tripeptide glutathione (GSH, L-gamma-glutamyl-L-cysteinylglycine) can function as an intracellular metal chelator, a metal detoxifying agent or a radical scavenger (HaMai and Bondy, 2004) . No significant changes were observed in glutathione levels for groups treated with MAC 18:1 and MAC 18:2 and subsequently exposed to MnCl 2 . However, in our study, 10 μM MnCl 2 had no significant effects on GSH levels in the U-87 MG cell line. This result is consistent with that of another study, in which changes in GSH levels were not observed in response to exposure of cerebellar granule neurons and cortical neurons to 11 μM and 110 μM MnCl 2 , respectively (Hernández et al., 2011) . In contrast, a reduction of GSH in response to exposure to 2 mM MnCl 2 for Fig. 3 . Evaluation of neuroprotective effects of macamides (0.3-10 μM) before 23 h exposure to 10 μM MnCl 2 in U-87 MG glioblastoma cells. Different concentrations of (A) MAC 18:1, (B) MAC 18:2 and (C) MAC 18:3 in the presence of the CB 1 antagonist AM251 failed to provide a neuroprotective effect against Mninduced toxicity, demonstrating the likely involvement of this cannabinoid receptor in neuroprotection. Data are presented as mean ± SEM (n = 3) and are expressed as percent of control viability. In the two-way ANOVA, followed by Tukey's test and compared to group with no cannabinoid antagonist (*), p ≤ 0.05 was considered significant. Fig. 4 . Effect of MAC 18:3 (0.1-50 μM) on endogenous glutathione (GSH) levels before 23 h exposure to 10 μM MnCl 2 in U-87 MG glioblastoma cells. Cells were treated with the indicated concentrations of MAC 18:3 followed by exposure to 10 μM MnCl 2 , to show the macamide's effect on endogenous GSH levels. Data are presented as mean ± SEM (n = 3). In the one-way ANOVA, followed by Tukey's test and compared to 10 μM MnCl 2 group (*), p ≤ 0.05 was considered significant. K.S. Gugnani et al. Toxicology and Applied Pharmacology 340 (2018) 67-76 48 h was previously reported in U-87 MG glioblastoma cells (Dukhande et al., 2006) . This result suggests the likelihood that GSH is reduced by exposures to higher concentrations of MnCl 2 for longer periods of time, thereby inducing oxidative stress and enhancing Mn-induced neurotoxicity. Of interest, exposure of cells to 10 μM and 30 μM MAC 18:3 before exposure to 10 μM MnCl 2 significantly increased GSH levels, compared to exposure to MnCl 2 alone. It is possible that higher concentrations of MAC 18:3 promote or upregulate GSH gene expression as a defense mechanism to counter Mn toxicity. It is known that heavy metals such as manganese, lead, silver, copper and zinc are responsible to cause mitochondrial dysfunction, disruption of cellular energy metabolism, oxidative stress and inflammation, as well as to alter neurotransmitter levels and to cause cell death by excitotoxicity (Lin and Beal, 2006; Uttara et al., 2009 ). The cell death observed in response to MnCl 2 exposure might be associated with mitochondrial depolarization (Rama Rao and Norenberg, 2004) . As expected, 50 μM MnCl 2 decreased mitochondrial membrane potential, as determined by JC-1 staining, and all the macamides tested significantly ameliorated this effect. Of interest, 10 μM MnCl 2 had no effect on mitochondrial depolarization, suggesting a different pathway or a different target to induce cell death. These possibilities need to be extensively investigated. JC-1, a lipophilic cation dye, exhibits a potential-dependent accumulation in mitochondria, indicated by a shift in fluorescence emission from red at 590 nm to green at 529 nm (CottetRousselle et al., 2011) . In healthy non-apoptotic cells, JC-1 dye enters the mitochondrial matrix, accumulates as aggregates and stains the mitochondria bright red, while in apoptotic cells MMP collapses, and JC-1 enters the cytoplasm in a monomeric form, which fluoresces green In the one-way ANOVA, followed by Tukey's test and compared to control group (**) and 50 μM MnCl 2 group (*), p ≤ 0.05 was considered significant. Quantitative data expressing mitochondrial depolarization in the presence of 50 μM MnCl 2 and effect of MAC 18:3 on MMP in the presence of MnCl 2 in U-87 MG glioblastoma cells using FACS. Data are presented as mean ± SEM (n = 3). In the one-way ANOVA, followed by Tukey's test and compared to control group (*), p ≤ 0.05 was considered significant. K.S. Gugnani et al. Toxicology and Applied Pharmacology 340 (2018) 67-76 ( Cottet-Rousselle et al., 2011) . Mitochondrial depolarization was indicated by a decrease in the red/green fluorescence intensity ratio (Garg and Chang, 2004) . Several reports suggest the involvement of Mn to reduce mitochondrial membrane potential by its effect on the ETC (Liu et al., 2013; Milatovic et al., 2007; Turrens and Boveris, 1980) . This reduction in membrane potential could be linked to rapid influx of Mn 2+ via calcium channels, dopamine active transporters (DAT; Anderson et al., 2007) or by divalent metal transporter 1 (DMT-1; Garrick et al., 2003 Garrick et al., , 2006 Yokel and Crossgrove, 2004) . The macamides tested were able to reverse the action of 50 μM MnCl 2 by significantly increasing the mitochondrial membrane potential. This result could be due to the interaction of macamides with ROS generated by subsequent Mn exposure , thereby preventing its toxic effect and/or reducing Mn influx (Fig. 9) . However, the mechanism for this observation will have to be determined by further experiments. Anandamide, the endocannabinoid known for its ability to interact with both CB 1 and CB 2 receptors, is also believed to interact with PPAR γ receptors (O'Sullivan, 2016 (O'Sullivan, , 2013 (O'Sullivan, , 2007 . Cannabinoids activate PPAR, either by acting as PPAR ligand or by formation of PPAR-active metabolites, which regulate target gene expression. (O'Sullivan, 2007) . Also, activation of certain cell surface receptors by cannabinoids might initiate intracellular signaling cascades that lead to the activation of PPAR (O'Sullivan, 2007) . Macamides, as they are structurally similar to AEA, should activate PPAR, particularly the PPAR γ receptor. PPAR γ activation was observed in the presence of RGZ, with an EC 50 of 240.8 ± 1.4 nM. No PPAR γ activation was observed in response to exposure to MAC 18:1. It was observed that MAC 18:2 and MAC 18:3 were responsible for PPAR γ activation with EC 50 values in the range of 20-25 μM. This observation is in agreement with results of a study which describes linoleic acid and linolenic acid as endogenous activators of PPAR γ , with EC 50 values in the range of 5-20 μM (Kliewer et al., 1997) . Therefore, the presence of the linoleic and linolenic acid backbones in macamides MAC 18:2 and MAC 18:3 makes these compounds suitable ligands for PPAR γ transactivation. This result is considered important in the study of the relationship between macamides and AEA. Moreover, it will be interesting to examine the effects of macamides that are mediated by PPAR γ.
Mitogen-activated protein kinases, characterized as proline-directed serine-threonine protein kinases, have been demonstrated to have a crucial role in regulating brain cell death and survival after ischemia (Zheng and Zuo, 2004) . Mitogen-activated protein kinases consist of three families: extracellular signal-regulated kinases (ERK), c-Jun Nterminal kinases (JNK), and p38 MAPK. After activation by phosphorylation of both Thr and Tyr residues, MAPK phosphorylates important intracellular enzymes and transcription factors (Irving and Bamford, 2002; Nozaki et al., 2001; Zheng and Zuo, 2004) . Inactivation of p38 MAPK was observed in the presence of 10 μM MnCl 2 , suggesting a mechanism for its neurotoxicity. MAC 18:3 was not successful to counteract this inactivation. This result opens a door to explore various other markers and proteins which might be involved in the macamides' neuroprotective activity.
Conclusion
Macamides have neuroprotective activity against Mn-induced Ratio of phosphorylated p38 MAPK to total p38 MAPK, normalized to control. Data are presented as mean ± SEM (n = 3; *p ≤ 0.05 as compared to control). Mn is neurotoxic by inactivating p38 MAPK. Anisomycin at 30 μM was used as positive control, demonstrating significant p38 MAPK activation. MAC 18:3 failed to counteract p38 MAPK inactivation induced by 10 μM MnCl 2 .
K.S. Gugnani et al. Toxicology and Applied Pharmacology 340 (2018) 67-76 mitochondrial depolarization and toxicity in U-87 MG glioblastoma cells. This neuroprotective action is believed to be through CB 1 mediated mechanisms. Macamides were able to maintain the mitochondrial membrane potential to prevent mitochondrial disruption otherwise caused by MnCl 2 . The neurotoxic effects of MnCl 2 could be confirmed by the downregulation of p38 MAPK. Inhibition of p38 MAPK might result in ROS generation, thereby resulting in neurotoxic effects. GSH levels were significantly higher in the presence of MAC 18:3, implying the upregulation of GSH, an antioxidant of critical importance in reducing ROS. Macamides, particularly MAC 18:2 and MAC 18:3 have multiple targets, interacting with nuclear receptor PPAR γ to regulate metabolism and energy homeostasis, cell differentiation, and inflammation. Based on the results of this study, macamides and other chemical constituents of Lepidium meyenii should be investigated further to elucidate their mechanisms of action and therapeutic utility.
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(B) Macamides demonstrate their ability to inhibit FAAH, thereby preventing intracellular degradation of AEA to arachidonic acid (Almukadi et al., 2013; Pino-Figueroa and Maher, 2009; Wu et al., 2013) . The increase in endogenous AEA levels is well documented for its role in neuroprotection (Martinez-Vargas et al., 2013; Nagayama et al., 1999; Schmid et al., 1995; Schomacher et al., 2008) . Since macamides and the endocannabinoid agonist AEA share structural similarities, macamides might be able to bind to the CB 1 receptor at its orthosteric site (Pertwee, 2015) . However, binding assays for macamides need to be investigated to assess the process of ligand-receptor binding. Exploring other proteins targets could further clarify the macamides' neuroprotective mechanisms.
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